Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute’s PROSPR Consortium
Douglas A. Corley, Mai Sedki, Debra P. Ritzwoller, Robert T. Greenlee, Christine Neslund‐Dudas, Katharine A. Rendle, Stacey Honda, Joanne E. Schottinger, Natalia Udaltsova, Anil Vachani, Sarah C. Kobrin, Christopher I. Li, Jennifer S. Haas
Topics & Concepts
PandemicCoronavirus disease 2019 (COVID-19)CancerSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineCoronavirusPerspective (graphical)DiseaseVirologyInfectious disease (medical specialty)Internal medicineOutbreakComputer scienceArtificial intelligenceCOVID-19 and healthcare impactsGlobal Cancer Incidence and ScreeningAdvances in Oncology and Radiotherapy